Small Molecule CMO/CDMO Market 2026 growing steadily to $78.41 billion by 2030

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Market Size Growth Is Projected For The Small Molecule CMO/CDMO Market During The Forecast Period 2026–2030?

The small molecule cmo/cdmo market size has shown robust growth recently. It is forecast to increase from $54.42 billion in 2025 to $58.55 billion in 2026, at a compound annual growth rate (CAGR) of 7.6%. This historical expansion can be linked to factors like the rise in generic drug manufacturing, the growing prevalence of chronic diseases, the broader scope of pharmaceutical R&D, the outsourcing of drug production, and a regulatory drive for quality and safety.

The small molecule cmo/cdmo market is projected to experience robust expansion over the coming years. This market is anticipated to reach $78.41 billion by 2030, achieving a compound annual growth rate (CAGR) of 7.6%. This projected growth stems from several factors, including a heightened demand for personalized medicine, increased funding into biologics and small-molecule hybrid treatments, market expansion in developing regions, progress in synthesis and formulation technologies, and the escalating requirement for expedited regulatory clearances. Key trends during this period are expected to encompass an expansion of contract development and manufacturing offerings, a greater embrace of continuous manufacturing methods, an increase in the custom synthesis of small-molecule APIs, an intensified emphasis on adhering to regulations and ensuring quality, and the formation of strategic collaborations between pharmaceutical firms and CMOs.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=13733&type=smp

Which Major Factors Are Driving The Expansion Of The Small Molecule CMO/CDMO Market?

The small-molecule CMO/CDMO market is expected to experience growth due to the increasing demand for pharmaceuticals. The pharmaceutical industry is a sector involved in the discovery, development, and production of drugs and medicines by both governmental and private entities. In this industry, small-molecule CMO/CDMO services are utilized to outsource various activities, including the development, manufacturing, and packaging of small-molecule drugs, thereby allowing pharmaceutical companies to reduce costs, save time, and streamline their processes. For instance, in January 2023, according to Cardinal Health Inc., a US-based healthcare company, the U.S. had 33 biosimilar products approved by the FDA as of January 2022, with 21 of them available on the market, and by 2023, the number of FDA-approved biosimilars had risen to 40, with 25 commercially available. This rising demand for pharmaceuticals is consequently driving the expansion of the small-molecule CMO/CDMO market.

What Market Segments Are Evaluated Within The Small Molecule CMO/CDMO Market?

The small molecule cmo/cdmo market covered in this report is segmented –

1) By Product: Small Molecule Drug Product, Small Molecule API

2) By Stage Type: Clinical, Commercial, Preclinical

3) By Therapeutic Area: Oncology, Neurology, Infectious Disease, Cardiovascular Disease, Respiratory Disorders, Metabolic Disorders, Other Therapeutics

4) By Application: Cardiovascular, Oncology, Diabetes, Immunological Disorders

Subsegments:

1) By Small Molecule Drug Product: Solid Dosage Forms (Tablets, Capsules), Liquid Dosage Forms (Injectables, Solutions), Topical Dosage Forms

2) By Small Molecule API (Active Pharmaceutical Ingredient): Generic APIs, Branded APIs, Custom Synthesis APIs

What Industry Trends Are Redefining The Small Molecule CMO/CDMO Market?

Major companies active in the small-molecule CMO/CDMO market are prioritizing innovative technologies, such as the advanced small-molecule platform in Shanghai, to improve CDMO services. This cutting-edge small-molecule platform represents the forefront of technological breakthroughs for developing and producing small-molecule drugs, aiming to create pharmaceutical compounds that are safer, more effective, and manufactured more efficiently. For instance, in June 2023, Porton Pharma Solutions Ltd., a China-based pharmaceutical firm, launched a state-of-the-art small-molecule platform in Shanghai, which enhanced its CDMO services. An advanced small molecule platform embodies a comprehensive strategy, merging leading technologies and methodologies to advance the entire lifecycle of small molecule pharmaceuticals, providing one-stop-shop solutions, an end-to-end platform, flexibility and availability, and digital transformation.

Who Are The Top Market Participants Influencing The Small Molecule CMO/CDMO Market?

Major companies operating in the small molecule cmo/cdmo market are Patheon NV (Thermo Fisher Scientific), Johnson Matthey plc, Lonza Group Ltd., WuXi AppTec, Catalent Inc., Aurobindo Pharma, Fareva, Aesica Pharmaceuticals Limited, Siegfried holdings AG, Recipharm AB, Jubilant Life Sciences Limited, Almac Group, Piramal Pharma Solutions, Oxford Chemicals Inc., Syngene International Limited, Novasep, Pfizer CentreOne, GVK Biosciences, ChemPartner, Dishman Carbogen Amcis Ltd, ProChem Inc., Metrics Contract Services

Read the full small molecule cmo/cdmo market report here:

https://www.thebusinessresearchcompany.com/report/small-molecule-cmo-or-cdmo-global-market-report

Which Region Currently Holds The Largest Share Of The Small Molecule CMO/CDMO Market?

North America was the largest region in the small molecule CMO/CDMO market in 2025. The regions covered in the small molecule cmo/cdmo market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Small Molecule CMO/CDMO Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=13733&type=smp

Browse Through More Reports Similar to the Global Small Molecule CMO/CDMO Market 2026, By The Business Research Company

Small Molecule Cmo Or Cdmo Market Report 2026

https://www.thebusinessresearchcompany.com/report/small-molecule-cmo-or-cdmo-global-market-report

Small Molecule Innovator Cdmo Market Report 2026

https://www.thebusinessresearchcompany.com/report/small-molecule-innovator-cdmo-global-market-report

Small Molecule Drug Discovery Market Report 2026

https://www.thebusinessresearchcompany.com/report/small-molecule-drug-discovery-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795